Frontiers in Medicine (Feb 2021)

Case Report: Identification of SARS-CoV-2 in Cerebrospinal Fluid by Ultrahigh-Depth Sequencing in a Patient With Coronavirus Disease 2019 and Neurological Dysfunction

  • Pan Xiang,
  • Xinmin Xu,
  • Xin Lu,
  • Lili Gao,
  • Huizhu Wang,
  • Zhenpeng Li,
  • Haofeng Xiong,
  • Ruihong Li,
  • Yanwen Xiong,
  • Lin Pu,
  • Tian Qin,
  • Fangfang Jin,
  • Hongyu Ren,
  • Chuansheng Li,
  • Jing Yang,
  • Ming Zhang,
  • Jie Gong,
  • Xiaoping Chen,
  • Han Zheng,
  • Jianbo Tan,
  • Yao Sun,
  • Fei Zhao,
  • Xuexin Hou,
  • Yufeng Liu,
  • Hebing Guo,
  • Jingjing Hao,
  • Biao Kan,
  • Haijian Zhou,
  • Yajie Wang,
  • Jingyuan Liu

DOI
https://doi.org/10.3389/fmed.2021.629828
Journal volume & issue
Vol. 8

Abstract

Read online

We reported that the complete genome sequence of SARS-Coronavirus-2 (SARS-CoV-2) was obtained from a cerebrospinal fluid (CSF) sample by ultrahigh-depth sequencing. Fourteen days after onset, seizures, maxillofacial convulsions, intractable hiccups and a significant increase in intracranial pressure developed in an adult coronavirus disease 2019 patient. The complete genome sequence of SARS-CoV-2 obtained from the cerebrospinal fluid indicates that SARS-CoV-2 can invade the central nervous system. In future, along with nervous system assessment, the pathogen genome detection and other indicators are needed for studying possible nervous system infection of SARS-CoV-2.

Keywords